October 4, 2018
Basis, an app-based platform that connects consumers with mental health counselors, announced the launch of its service alongside a $3.75 million funding round. The investment was led by Bedrock, with support from Wave Capital and Lightspeed Venture Partners.
Headlined by CEO Andrew Chapin, a former Uber executive, and Chief Science Officer Lindsay Trent, a clinical psychologist at Stanford,...
Photo credit: The Royal Foundation
September 11, 2018
The British royal family is now turning its attention to online resources as a means of promoting mental wellbeing in the workplace. Earlier this week Prince William, Duke of Cambridge, launched Mental Health at Work, which aims to help link employers and employees to information and resources about mental health. The platform is supported by the Royal Foundation, a charity run by the junior...
September 10, 2018
Philadelphia-based mental health technology company NeuroFlow has raised $1.2 million, and anticipates a total subscription of $1.5 million by the conclusion of its ongoing fundraising, the company announced today. The investment was led by NJ JumpStart, with additional participation from Independence Blue Cross, Chestnut Street Ventures, and Ben Franklin Technology Partners.
“With product demand...
August 16, 2018
WellBrain, a Bay Area meditation-focused addiction prevention and chronic pain management platform, announced yesterday that it has acquired Mevoked, a behavioral analytics platform that currently offers a digital program for management of perinatal and postpartum mental health conditions. The terms of the deal were not disclosed.
Inspired by the meditation practices of Tibetian monks, WellBrain’...
July 9, 2018
The UK's National Health Service (NHS) will launch a new wide-ranging app in December that allows all patients to book appointments, consult their medical records, and more, the government agency announced last week. Though many of the features are already available online, the new app will bring them together into one mobile access point.
"I want this innovation to mark the death-knell of the 8...
June 22, 2018
Behavioral health technology company AbleTo has raised an additional $8.5 million in funding, according to an SEC filing released Wednesday.
The company most recently brought in $36.6 million in September 2017, and with the additional backing has raised a total of $65.9 million. Its existing backers include Bain Capital Ventures, 406 Ventures, Sandbox Industries, HLM Venture Partners, Horizon...
May 7, 2018
Digital behavioral health company Lyra Health announced today that it has secured a $45 million Series B round of funding. Participants in the round included new investors Tenaya Capital, Glynn Capital, Crown Ventures, and Casdin Capital, as well as returning funders Greylock Partners, Venrock, and Providence Ventures.
According to a statement, the new funding will be put toward developing...
February 27, 2018
St. Petersburg, Florida-based TAO Connect is making its digital self-help and therapy tool direct to consumers for the first time, after previously offering it via schools, community health centers, and employee assistance plans.
The company will offer a monthly subscription to its mobile app, which contains interactive educational content around stress, anxiety, resilience training, alcohol and...
February 12, 2018
Correction: A previous version of this article misstated Provata's 2016 revenue.
Merck subsidiary StayWell, which offers a preventative health platform for employers, health plans, and health systems, has acquired Provata Health for an undisclosed sum. Provata Health makes a digital health platform for employee wellness, which includes a chronic disease management program incorporating a...
December 27, 2017
Digital health in pharma definitely had a milestone moment in the fourth quarter with the FDA approval of Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia powered by Proteus Digital Health’s ingestible sensor technology. In addition to that, the quarter saw numerous other moves by pharma companies around clinical trials, chronic disease management, mental health,...